Comparative effects of three beta blockers (atenolol, metoprolol, and propranolol) on survival after acute myocardial infarction∗∗The views expressed in this article do not necessarily reflect the official position of the Health Care Financing Administration.

This publication has 11 references indexed in Scilit:

• Effect of Beta-Blockade on Mortality among High-Risk and Low-Risk Patients after Myocardial Infarction
  New England Journal of Medicine, 1998
• Clinical Relevance of Pharmacokinetic Differences Between Beta Blockers
  The American Journal of Cardiology, 1997
• Exercise metabolism during 1 hour of treadmill walking while taking high and low doses of propranolol, metoprolol, or placebo
  Clinical Cardiology, 1995
• Cardiac vagal activity: a target for intervention in heart disease
  The Lancet, 1995
• Role of central nervous beta-adrenoceptors in the prevention of ventricular fibrillation through augmentation of cardiac vagal tone
  Journal of the American College of Cardiology, 1991
• Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.
  Circulation Research, 1986
• APACHE II
  Critical Care Medicine, 1985
• Can the biochemical responses to a beta 2‐adrenoceptor stimulant be used to assess the selectivity of beta‐adrenoceptor blockers?
  British Journal of Clinical Pharmacology, 1983
• Treatment of myocardial infarction in a coronary care unit
  The American Journal of Cardiology, 1967
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958